As a physician, Ive seen a growing need for a more personalized, gentler approach: microdosing
Providers should approach GLP-1 therapy the way they approach antihypertensives or statins: as long-term tools for a chronic condition, with discontinuation decisions made based on clinical indication rather than an arbitrary treatment timeline
Experimental data indicate GLP1-S enhances peripheral glucose uptake, lowers hepatic glucose output, and slows gastric emptying
de Mello AH, Schraiber RB, Goldim MPS, Garcez ML, Gomes ML, de Bem Silveira G, Zaccaron RP, Schuck PF, Budni J, Silveira PCL, Petronilho F, Rezin GT (2019) Omega-3 fatty acids attenuate brain alterations in High-Fat Diet-Induced obesity model